Find Information About:

Drugs & Supplements

Get information and reviews on prescription drugs, over-the-counter medications, vitamins, and supplements. Search by name or medical condition.

Pill Identifier

Pill Identifier

Having trouble identifying your pills?

Enter the shape, color, or imprint of your prescription or OTC drug. Our pill identification tool will display pictures that you can compare to your pill.

Get Started
My Medicine

My Medicine

Save your medicine, check interactions, sign up for FDA alerts, create family profiles and more.

Get Started

WebMD Health Experts and Community

Talk to health experts and other people like you in WebMD's Communities. It's a safe forum where you can create or participate in support groups and discussions about health topics that interest you.

  • Second Opinion

    Second Opinion

    Read expert perspectives on popular health topics.

  • Community


    Connect with people like you, and get expert guidance on living a healthy life.

Got a health question? Get answers provided by leading organizations, doctors, and experts.

Get Answers

Sign up to receive WebMD's award-winning content delivered to your inbox.

Sign Up

Cancer Health Center

Font Size

Down Syndrome Yields Key Cancer Clue

Genes Overproduced in Down Syndrome Can Slow Tumor Growth
WebMD Health News
Reviewed by Louise Chang, MD

May 20, 2009 -- People with Down syndrome hold the key to a new generation of cancer drugs, researchers say.

Solid tumors are very rare in people with Down syndrome. Why? The answer almost certainly lies among the 231 extra genes they inherit with their extra copy of chromosome 21.

Narrowing the search for the anti-cancer gene is another observation: People with Down syndrome rarely get diseases linked to the overgrowth of blood vessels.

Might the anti-cancer effect of Down syndrome be linked to something that blocks the growth of new blood vessels? To find out, Sandra Ryeom, PhD, and colleagues at Children's Hospital Boston designed a clever series of experiments.

One of the genes on chromosome 21 encodes a protein that blocks a factor needed for blood vessel growth. They found that this protein, DSCR1, is overproduced in people with Down syndrome. It's also overproduced in about the same amounts in a mouse model of Down syndrome.

Might the extra protein really affect blood vessel growth? When Ryeom and colleagues looked at tumors grown from Down syndrome stem cells, they saw that these cancer cells had fewer blood vessels than cancers grown from normal stem cells.

Further experiments confirmed that DSCR1 inhibited angiogenesis, or blood vessel growth.

Given that people with Down syndrome have 231 extra genes, it's improbable that DSCR1 is the only one with anti-cancer effects. And Ryeom and colleagues found evidence that another chromosome 21 gene, Dyrk1A, contributes to the anti-angiogenesis effect.

"I think there may be four or five genes on chromosome 21 that are necessary for angiogenesis suppression," Ryeom says in a news release.

"It is, perhaps, inspiring that the Down syndrome population provides us with new insight into mechanisms that regulate cancer growth and, by so doing, identifies potential targets for tumor prevention and therapy," Ryeom and colleagues conclude.

The findings appear in the early online edition of the journal Nature.

Today on WebMD

Colorectal cancer cells
New! I AM Not Cancer Facebook Group
Lung cancer xray
See it in pictures, plus read the facts.
sauteed cherry tomatoes
Fight cancer one plate at a time.
Ovarian cancer illustration
Real Cancer Perspectives
Jennifer Goodman Linn self-portrait
what is your cancer risk
colorectal cancer treatment advances
breast cancer overview slideshow
prostate cancer overview
lung cancer overview slideshow
ovarian cancer overview slideshow
Actor Michael Douglas